The Carlyle Group Inc. reports developments as a global investment firm that deploys private capital through Global Private Equity, Global Credit, and Carlyle AlpInvest. Company news commonly covers financial results, fee-related earnings, fundraising, inflows, distributable earnings, shareholder updates, capital allocation, and share repurchase activity.
Carlyle updates also include partnerships that broaden private-market access for wealth and retirement channels, activity involving private equity, credit, real estate, and infrastructure strategies, and financing or transaction developments tied to its investment platform and portfolio companies.
Pharmapacks, an ecommerce enablement platform, secured over $250 million from The Carlyle Group (NASDAQ: CG) to boost growth, raising its enterprise value to approximately $1.1 billion. The funds will enhance partnerships with consumer brands and expand its logistics capabilities. Pharmapacks achieved over $250 million in sales in 2019 and is on track for 60% year-over-year growth, supported by a new 230k square foot fulfillment center. Carlyle's investment underscores its commitment to fast-growing consumer brands amidst the expanding ecommerce landscape.
On September 21, 2020, The Carlyle Group (NASDAQ: CG) announced a strategic growth investment in TriNetX, acquiring a majority stake in the global health research network. While the transaction details remain undisclosed, TriNetX has established a vast network of 170 healthcare organizations across 30 countries. The investment aims to enhance TriNetX's capabilities in clinical research and accelerate its growth, leveraging AI and analytics. Carlyle's involvement aligns with its long-term healthcare commitment, having invested over $15 billion in the sector.